This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by McMillan, M. R. Articles by Nugent, W. Search for Related Content PubMed PubMed Citation Articles by McMillan, M. R. Articles by Nugent, W. Related Collections Equipment Pain

---

PAIN MEDICINE

Catheter-Associated Masses in Patients Receiving Intrathecal Analgesic Therapy

Foothills Regional Pain Center and Mountainview Medical Imaging, Seneca, South Carolina

Address correspondence and reprint requests to Marion R. McMillan, MD, Foothills Regional Pain Center, 457 Sandifer Blvd., Seneca, SC 29678. Address e-mail to marionmc{at}worldnet.att.net

A cohort of seven patients receiving intrathecal analgesic drug therapy for chronic intractable pain underwent radiocontrast myelography and computed tomography (CT) scanning to screen for catheter-associated intrathecal masses. Three of seven patients examined had intraspinal masses associated with the tip of the drug infusion catheter after a total of 118 mo of therapy. The index case presented with exacerbation of neuropathic pain and paralysis of the left lower extremity. The two additional cases detected by CT myelography were asymptomatic at the time the catheter-associated mass was assessed. The mean duration of therapy before diagnosis of the catheter-associated mass was 19.6 mo, with a range of 16–25 mo. An intergroup comparison of demographic and treatment variables between patients, with and without catheter-associated masses, demonstrated that patients with masses were younger and were receiving a larger morphine dose than patients without masses. The differences were statistically significant (P = 0.05). In one patient with an asymptomatic catheter-associated intrathecal mass, regression of the mass was observed after cessation of therapy. In a second asymptomatic patient, the mass remained stable over 1 yr of continued treatment after substitution of hydromorphone for morphine without interruption of therapy. Neither asymptomatic patient has subsequently developed additional neurologic findings or injury after detection of occult catheter-associated intrathecal masses and clinical intervention. We suggest that all patients receiving long-term intrathecal analgesia should undergo periodic radiographic surveillance to further define their risk of developing occult catheter-associated masses and to allow intervention before neurologic injury can develop.

IMPLICATIONS: Catheter-associated intrathecal masses were detected in three of seven patients receiving long-term intrathecal analgesia. In the two asymptomatic patients, timely clinical intervention was associated with the avoidance of subsequent neurologic injury and spontaneous resolution of one of the occult masses.

This article has been cited by other articles:

				P. K. Singh, R. Jain, S. Mishra, S. Kumar, S. Bhatnagar, and S. Deo Management of Pericatheter Cerebrospinal Fluid Leak After Intrathecal Implantation of a Drug Delivery System American Journal of Hospice and Palliative Medicine, June 1, 2008; 25(3): 237 - 239. [Abstract] [PDF]

				V. L. Ghafoor, M. Epshteyn, G. H. Carlson, D. M. Terhaar, O. Charry, and P. K. Phelps Intrathecal drug therapy for long-term pain management Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2447 - 2461. [Abstract] [Full Text] [PDF]

				J. A. Phillips, E. J. Escott, J. J. Moossy, and H. C. Kellermier Imaging Appearance of Intrathecal Catheter Tip Granulomas: Report of Three Cases and Review of the Literature Am. J. Roentgenol., December 1, 2007; 189(6): W375 - W381. [Abstract] [Full Text] [PDF]

				G. Meta, A. Ghaleb, W. B. Gentry, and J. Firnhaber Intrathecal therapy-associated masses. Anesth. Analg., July 1, 2006; 103(1): 260 - 261. [Full Text] [PDF]

				P. M. Murphy, D. E. Skouvaklis, R. J.J. Amadeo, C. Haberman, D. H. Brazier, and M. J. Cousins Intrathecal catheter granuloma associated with isolated baclofen infusion. Anesth. Analg., March 1, 2006; 102(3): 848 - 852. [Abstract] [Full Text] [PDF]

				I. Ikushima, T. Hirai, Y. Korogi, M. Norio, M. Koganemaru, R. Suga, S. Morishita, and Y. Yamashita Spinal MR Findings in Continuous Epidural Analgesia without Infection AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 991 - 995. [Abstract] [Full Text] [PDF]

				L. Baker, M. Lee, C. Regnard, L. Crack, and S. Callin Evolving spinal analgesia practice in palliative care Palliative Medicine, September 1, 2004; 18(6): 507 - 515. [Abstract] [PDF]

				A. P. Gulve, S. Eldabe, J. Richardson, I. Rice, and M. Y. K Wee Obstetric epidural and chronic adhesive arachnoiditis Br. J. Anaesth., May 1, 2004; 92(5): 765 - 767. [Full Text] [PDF]